NÜMUNƏ ƏLİYEVA

Liv Bona Dea Hospital Bakü

Revmatologiya

Xəstəxana

Sahə seçin

Bütün sahələr

Günortadan əvvəl

Günortadan sonra

Mövcud randevu saatları və məlumat üçün Zəng Mərkəzimizə 012 525 09 00 nömrəsinə zəng edə bilərsiniz.

Randevu təyin edin

Fəaliyyət Sahələri

• Revmatoid artrit, juvenil idiopatik artrit
• Osteoartrit
• Kristal artropatiler (gut, kalsiyum pirofosfat depolanma xəstəliyi və digərləri)
• Seronegativ spondiloartritlər (Ankilozan spondilit, psöriatik artrit, reaktiv artrit, enteropatik artrit)
• Sistemik Lupus Eritematozus, antifosfolipid sendrom
• Raynaud (Reyno) sendromu, sistemik skleroz (sklerodermiya), mikst birləşdirici toxuma xəstəliyi, differensiasiya olmamış birləşdirici toxuma xəstəliyi
• Dermatomyozit, polimyozit
• Sjögren sindromu (primer, sekonder)
• Fibromialgia
• Vaskülitlər
• Ailəvi aralıq dənizi qızdırması, diğər otoinflamatuvar xəstəliklər• IgG4 əlaqəli xəstəlik
• Osteoporoz

Təhsil:

Azərbaycan Tibb Universiteti Müalicə İşi və Profilaktika Fakultəsi 2005-2011
İstanbul Tibb Fakültəsi Daxili Xəstəliklər Kafedrasında uzmanlıq təhsili 2013-2017
İstanbul Tibb Fakültəsi Revmatologiya şöbəsinde yandal uzmanlıq təhsili 2018-2021

İş təcrübəsi:

Liv Hospital Bonadea
Baku Medikal Plaza VIP
Via Hospital Istanbul

Məqalə:

Sistemik Lupus Eritematozus ve Antifosfolipid Sendrom Tanılı Hastalarda Trombotik Riskin Değerlendirilmesine Yönelik Bileşik Tromboz Risk Skoru’nun Validasyonu ve Etkinliğinin aGAPSS (adjusted global antiphospholipid syndrome score) Skoru ile Karşılaştılması
Sistemik Lupus Erıtematozusta Hastalık İlişkili Hasarın COVID-19 İnfeksiyonu Seyrine Olumsuz Etkileri
Dermatomyozit hastalarında periferik vaskülopatinin tırnak dibi kapillaroskopisi ile değerlendirilmesi ve mikrosirkülasyondaki anormal bulguların tanımlanması
İmmünsupresif Tedaviye Dirençli Sistemik Skleroz Hastalarında Rituksimab Tedavisi ile Hastalık Aktivitesi, Hastalık Şiddeti ve Hastalıkla İlişkili Hasar Bulgularının Seyri
Skleroderma Renal Kriz: Tek Merkezde izlenen Sistemik Skleroz Hastalarında Sıklığı ve Klinik Özellikleri
Ciddi Periferik Vasküler Hasra Nedeniyle Periferik Vazodilatatör Kullanan Sistemik Skleroz Hastalarının Klinik ve Tedavi Özellikleri
Sıstemık Skleroz Hastalarında COVID-19 infeksiyonu Sıklığı ve Klinik Seyri: Tek Merkez Deneyimi
Biyolojik Ajan Kullanan Ailevi Akdeniz Atesi Hastalarında COVID-19 Olumlu Seyri
Kolşisine yetersiz yanıt nedeniyle anti IL-1 tedavi alan Ailevi Akdeniz Ateşi hastalarının retrospektif incelenmesi
Criteria for the hyperinflammation developing in coronavirus disease-19: analysis of two cohorts from different periods of the pandemic
The importance of parental consanguinity and family history of kidney disease in the Turkish adult chronic kidney disease population: An epidemiologic study

Nəşrlər:

A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis (Exp Clin Transplant 2017 Mar 28. doi: 10.6002/ect.2016.0066)
Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients (A Transplant Proc. 2019 May;51(4):1118-1120. doi:10.1016/j.transproceed.2019.01.106)
Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyel spondiloartritli hastalarda klinik özellikler ve tedavi sonuçları (Ulusal Romatoloji Dergisi / Journal of Turkish Society for Rheumatology • Cilt / Volume 13 • Sayı / Issue 3 • Aralık / December 2021)
Genetic Screening of Early-Onset Patients with Systemic Lupus Erythematosus by A Targeted Next-Generation Sequencing Gene Panel (Lupus. 2022 Jan 27:9612033221076733. doi: 10.1177/09612033221076733)
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine (Journal of Medical Virology •21 March 2022 https://doi.org/10.1002/jmv.27731)
Hakemli tibbi dergilerde yayinlanan ve uluslararasi kongrelerde poster sunumlar
The Efficacy and Safety of Rituximab in 26 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (6th Systemic Sclerosis World Congress HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.321; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367 )
The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (6th Systemic Sclerosis World Congress HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.147; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367 )
Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (6th HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/"Systemic Sclerosis World Congress HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" HYPERLINK "https://web.aimgroupinternational.com/2020/sclerosiscongress/" 2020) (P.148; Journal of Scleroderma and Related Disorders 2020, Vol. 5(1S) 1–307; https://doi.org/10.1177/2397198319898367
The relationship Between Disease Activity and Severity in Systemic Sclerosis: A Prospective Analysis of 278 Patients (EULAR 2020) (THU0349; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6129 )
The Efficacy and Safety of Rituximab in 27 Cases of Treatment Resistant Systemic Sclerosis with Severe Disease Assessed by Activity Scores (EULAR 2020) (STAO346: http://dx.doi.org/10.1136/annrheumdis-2020-eular.6053)
Evaluation of Different Classification Criteria in Systemic Sclerosis in a Turkish Cohort: The Importance of Non-Skin Manifestations, Serology and Capillaroscopy (EULAR 2020) (THU369; http://dx.doi.org/10.1136/annrheumdis-2020-eular.6000)
Favourable Short-term Course of COVID-19 in Patients with Familial Mediterranean Fever Using Biologic Agents (EULAR 2021) (POS1259; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3903)
Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center Cohort (EULAR 2021) (ABO448; http://dx.doi.org/10.1136/annrheumdis-2021-eular.3460)
Course of COVID-19 Infection in a Series of Patients with Systemic Lupus Erythematosus (EULAR 2021) (ABO653; http://dx.doi.org/10.1136/annrheumdis-2021-eular.368)
Systemic Sclerosis Associated Pulmonary Hypertension: Predominance of Pulmonary Fibrosis as a Risk Factor for Mortality in a Single Center SSC-PH Cohort (7th Systemic Sclerosis World Congress; ID 255)
Frequency and Clinical Characteristics of Scleroderma Renal Crisis from Turkey: Most Patients Do Not Have a Treatment History of High Dose Corticosteroids and ACE Inhibitors (7th Systemic Sclerosis World Congress; ID 260)
COVID-19 Infections in Patients with Systemic Sclerosis: Factors Associated with Hospitalization (7 th Systemic Sclerosis World Congress; ID 260)